iX Biopharma off to good start amid penny party

iX Biopharma off to good start amid penny party
Mr Eddy Lee, CEO and chairman of iX Biopharma. The pharmaceutical company debuted on the Catalist board by opening 7.6 per cent above its initial public offer price of 46 cents, before closing 6.5 cents or 21.74 per cent higher at 56 cents.
PHOTO: The Business Times

More about

Purchase this article for republication.

BRANDINSIDER

SPONSORED

Most Read

Your daily good stuff - AsiaOne stories delivered straight to your inbox
By signing up, you agree to our Privacy policy and Terms and Conditions.